What's new

EMEA-003192-PIP02-23

EMEA-003192-PIP02-23

Jun 23, 2025 - 16:30
 0
EMEA-003192-PIP02-23
EMEA-003192-PIP02-23
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,v...

Next Article

Human medicines European public assessment report (EPAR): Entresto, sacubitril,v...

Related Posts

Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0

Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 15/05/2025 Positive

Summary of opinion: Bluevac BTV (previously Bluevac BTV...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0